|
1
|
Yun JW: Possible anti-obesity therapeutics
from nature-a review. Phytochemistry. 71:1625–1641. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mitchell M, Armstrong DT, Robker RL and
Norman RJ: Adipokines: Implications for female fertility and
obesity. Reproduction. 130:583–597. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kunitomi M, Wada J, Takahashi K,
Tsuchiyama Y, Mimura Y, Hida K, Miyatake N, Fujii M, Kira S,
Shikata K and Maknio H: Relationship between reduced serum IGF-I
levels and accumulation of visceral fat in Japanese men. Int J Obes
Relat Metab Disord. 26:361–369. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hida K, Wada J, Eguchi J, Zhang H, Baba M,
Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, et al:
Visceral adipose tissue-derived serine protease inhibitor: A unique
insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci
USA. 102:10610–10615. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolf G, Chen S, Han DC and Ziyadeh FN:
Leptin and renal disease. Am J Kidney Dis. 39:1–11. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamauchi T, Kamon J, Waki H, Imai Y,
Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, et al:
Globular adiponectin protected ob/ob mice from diabetes and
ApoE-deficient mice from atherosclerosis. J Biol Chem.
278:2461–2468. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sakaue H, Nishizawa A, Ogawa W,
Teshigawara K, Mori T, Takashima Y, Noda T and Kasuga M:
Requirement for 3-phosphoinositide-kependent dinase-1 (PDK-1) in
insulin-induced glucose uptake in immortalized brown adipocytes. J
Biol Chem. 278:38870–38874. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seufert J, Lübben G, Dietrich K and Bates
PC: A comparison of the effects of thiazolidinediones and metformin
on metabolic control in patients with type 2 diabetes mellitus.
Clin Ther. 26:805–818. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Inzucchi SE: Oral antihyperglycemic
therapy for type 2 diabetes: Scientific review. JAMA. 287:360–372.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sicińska P, Pytel E, Maćczak A and
Koter-Michalak M: The use of various diet supplements in metabolic
syndrome. Postepy Hig Med Dosw (Online). 69:25–33. 2015.(In
Polish). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Parodi PW: Cows' milk fat components as
potential anticarcinogenic agents. J Nutr. 127:1055–1060.
1997.PubMed/NCBI
|
|
12
|
Lee KN, Kritchevsky D and Pariza MW:
Conjugated linoleic acid and atherosclerosis in rabbits.
Atherosclerosis. 108:19–25. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parker J, Daniel LW and Waite M: Evidence
of protein kinase C involvement in phorbol diester-stimulated
arachidonic acid release and prostaglandin synthesis. J Biol Chem.
262:5385–5393. 1987.PubMed/NCBI
|
|
14
|
Banni S, Carta G, Angioni E, Murru E,
Scanu P, Melis MP, Bauman DE, Fischer SM and Ip C: Distribution of
conjugated linoleic acid and metabolites in different lipid
fractions in the rat liver. J Lipid Res. 42:1056–1061.
2001.PubMed/NCBI
|
|
15
|
Pariza MW, Park Y and Cook M: The
biologically active isomers of conjugated linoleic acid. Prog Lipid
Res. 40:283–298. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bocher V, Pineda-Torra I, Fruchart JC and
Staels B: PPARs: Transcription factors controlling lipid and
lipoprotein metabolism. Ann N Y Acad Sci. 967:7–18. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Granlund L, Pedersen JI and Nebb HI:
Impaired lipid accumulation by trans10, cis12 CLA during adipocyte
differentiation is dependent on timing and length of treatment.
Biochim Biophys Acta. 1687:11–22. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hue JJ, Lee KN, Jeong JH, Lee SH, Lee YH,
Jeong SW, Nam SY, Yun YW and Lee BJ: Anti-obesity activity of
diglyceride containing conjugated linoleic acid in C57BL/6J ob/ob
mice. J Vet Sci. 10:189–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hill AJ, Peikin SR, Ryan CA and Blundell
JE: Oral administration of proteinase inhibitor II from potatoes
reduces energy intake in man. Physiol Behav. 48:241–246. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schwartz JG, Guan D, Green GM and Phillips
WT: Treatment with an oral proteinase inhibitor slows gastric
emptying and acutely reduces glucose and insulin levels after a
liquid meal in type II diabetic patients. Diabetes Care.
17:255–262. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Levitt J: The isolation and preliminary
fractionation of proteins from dormant and growing potato tubers.
Plant Physiol. 26:59–65. 1951. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bryant J, Green TR, Gurusaddaiah T and
Ryan CA: Proteinase inhibitor II from potatoes: Isolation and
characterization of its protomer components. Biochemistry.
15:3418–3424. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim MH, Park SC, Kim JY, Lee SY, Lim HT,
Cheong H, Hahm KS and Park Y: Purification and characterization of
a heat-stable serine protease inhibitor from the tubers of new
potato variety ‘Golden Valley’. Biochem Biophys Res Commun.
346:681–686. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vlachojannis JE, Cameron M and Chrubasik
S: Medicinal use of potato-derived products: A systematic review.
Phytother Res. 24:159–162. 2010.PubMed/NCBI
|
|
25
|
Komarnytsky S, Cook A and Raskin I: Potato
protease inhibitors inhibit food intake and increase circulating
cholecystokinin levels by a trypsin-dependent mechanism. Int J Obes
(Lond). 35:236–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peters HP, Foltz M, Kovacs EM, Mela DJ,
Schuring EA and Wiseman SA: The effect of protease inhibitors
derived from potato formulated in a minidrink on appetite, food
intake and plasma cholecystokinin levels in humans. Int J Obes
(Lond). 35:244–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim JD, Kang SM, Park MY, Jung TY, Choi HY
and Ku SK: Ameliorative anti-diabetic activity of dangnyosoko, a
Chinese herbal medicine, in diabetic rats. Biosci Biotechnol
Biochem. 71:1527–1534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sahai A, Malladi P, Pan X, Paul R,
Melin-Aldana H, Green RM and Whitington PF: Obese and diabetic
db/db mice develop marked liver fibrosis in a model of nonalcoholic
steatohepatitis: Role of short-form leptin receptors and
osteopontin. Am J Physiol Gastrointest Liver Physiol.
287:G1035–G1043. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jung YM, Lee SH, Lee DS, You MJ, Chung IK,
Cheon WH, Kwon YS, Lee YJ and Ku SK: Fermented garlic protects
diabetic, obese mice when fed a high-fat diet by antioxidant
effects. Nutr Res. 31:387–396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim JD, Kang SM, Seo BI, Choi HY, Choi HS
and Ku SK: Anti-diabetic activity of SMK001, a poly herbal formula
in streptozotocin induced diabetic rats: Therapeutic study. Biol
Pharm Bull. 29:477–482. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Edwin N and Leigh CM: Immunocytochemical
identification of islet cells containing calcitonin gene-related
peptide-like immunoreactivity in the plains rat pancreas
(Pseudomys australis). Singapore Med J. 40:528–530.
1999.PubMed/NCBI
|
|
32
|
Lee HS, Chang JH and Ku SK: An
immunohistochemical study of the pancreatic endocrine cells of the
ddN mouse. Folia Histochem Cytobiol. 48:387–393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ng M, Fleming T, Robinson M, Thomson B,
Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF,
et al: Global, regional, and national prevalence of overweight and
obesity in children and adults during 1980–2013: A systematic
analysis for the Global Burden of Disease Study 2013. Lancet.
384:766–781. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liese AD, Mayer-Davis EJ and Haffner SM:
Development of the multiple metabolic syndrome: An epidemiologic
perspective. Epidemiol Rev. 20:157–172. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Deen D: Metabolic syndrome: Time for
action. Am Fam Physician. 69:2875–2882. 2004.PubMed/NCBI
|
|
36
|
Morange PE, Lijnen HR, Alessi MC, Kopp F,
Collen D and Juhan-Vague I: Influence of PAI-1 on adipose tissue
growth and metabolic parameters in a murine model of diet-induced
obesity. Arterioscler ThrombVasc Biol. 20:1150–1154. 2000.
View Article : Google Scholar
|
|
37
|
Fujita H, Fujishima H, Koshimura J, Hosoba
M, Yoshioka N, Shimotomai T, Morii T, Narita T, Kakei M and Ito S:
Effects of antidiabetic treatment with metformin and insulin on
serum and adipose tissue adiponectin levels in db/db mice. Endocr
J. 52:427–433. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bjørbaek C and Kahn BB: Leptin signaling
in the central nervous system and the periphery. Recent Prog Horm
Res. 59:305–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Scherer PE, Williams S, Fogliano M,
Baldini G and Lodish HF: A novel serum protein similar to C1q,
produced exclusively in adipocytes. J Biol Chem. 270:26746–26749.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Maeda K, Okubo K, Shimomura I, Funahashi
T, Matsuzawa Y and Matsubara K: CDNA cloning and expression of a
novel adipose specific collagen-like factor, apM1 (AdiPose Most
abundant Gene transcript 1). Biochem Biophys Res Commun.
221:286–289. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Arita Y, Kihara S, Ouchi N, Takahashi M,
Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K,
et al: Paradoxical decrease of an adipose-specific protein,
adiponectin, in obesity. Biochem Biophys Res Commun. 257:79–83.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Matsubara M: Plasma adiponectin decrease
in women with nonalcoholic Fatty liver. Endocr J. 51:587–593. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Maebuchi M, Machidori M, Urade R, Ogawa T
and Moriyama T: Low resistin levels in adipose tissues and serum in
high-fat fed mice and genetically obese mice: Development of an
ELISA system for quantification of resistin. Arch Biochem Biophys.
416:164–170. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tasso F, Clop J and Sarles H: The
interaction of ethanol, dietary lipids and proteins on the rat
pancreas. II. Ultrastructural study. Digestion. 4:23–34. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wilson JS, Korsten MA, Leo MA and Lieber
CS: Combined effects of protein deficiency and chronic ethanol
consumption on rat pancreas. Dig Dis Sci. 33:1250–1259. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hiatt JL and Gartner LP: Color textbook of
histology. WB Saunders Co. Philadelphia USA: 1–592. 2007.
|
|
47
|
Sathishsekar D and Subramanian S:
Beneficial effects of Momordica charantia seeds in the
treatment of STZ-induced diabetes in experimental rats. Biol Pharm
Bull. 28:978–983. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Terauchi Y, Takamoto I, Kubota N, Matsui
J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, et al:
Glucokinase and IRS-2 are required for compensatory beta cell
hyperplasia in response to high-fat diet-induced insulin
resistance. J Clin Invest. 117:246–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kamada T, Hata J, Kusunoki H, Ito M,
Tanaka S, Kawamura Y, Chayama K and Haruma K: Eradication of
Helicobacter pylori increases the incidence of
hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver
Dis. 37:39–43. 2005. View Article : Google Scholar : PubMed/NCBI
|
